InsiderTrades.com logo

DRUG Insider Trading

Insider Ownership Percentage: 42.66%
Insider Buying (Last 12 Months): $2,060,428.23
Insider Selling (Last 12 Months): $0.00

Bright Minds Biosciences Insider Trading History Chart

This chart shows the insider buying and selling history at Bright Minds Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Bright Minds Biosciences Share Price & Price History

Current Price: $35.78
Price Change: ▼ Price Decrease of -0.28 (-0.78%)
As of 03/14/2025 05:00 PM ET

This chart shows the closing price history over time for DRUG up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Bright Minds Biosciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/15/2024Cormorant Asset Management, LpMajor ShareholderBuy372,591$5.53$2,060,428.23825,000View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Bright Minds Biosciences (NASDAQ:DRUG)

40.52% of Bright Minds Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at DRUG by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Bright Minds Biosciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/17/2025Point72 Asset Management L.P.135,189$4.87M0.0%N/A3.049%Search for SEC Filing on Google Icon
2/17/2025Millennium Management LLC40,379$1.45M0.0%N/A0.911%Search for SEC Filing on Google Icon
2/17/2025Janus Henderson Group PLC508,776$18.39M0.0%N/A11.485%Search for SEC Filing on Google Icon
2/17/2025Bank of America Corp DE4,793$0.17M0.0%N/A0.108%Search for SEC Filing on Google Icon
2/17/2025Acuta Capital Partners LLC69,124$2.49M2.5%N/A1.560%Search for SEC Filing on Google Icon
2/14/2025RA Capital Management L.P.460,829$16.60M0.2%N/A10.402%Search for SEC Filing on Google Icon
2/14/2025Jane Street Group LLC6,600$0.24M0.0%N/A0.149%Search for SEC Filing on Google Icon
2/14/2025Schonfeld Strategic Advisors LLC69,812$2.47M0.0%N/A1.576%Search for SEC Filing on Google Icon
2/14/2025AdvisorShares Investments LLC3,075$0.11M0.0%-98.3%0.069%Search for SEC Filing on Google Icon
2/14/2025Boothbay Fund Management LLC44,580$1.61M0.0%N/A1.006%Search for SEC Filing on Google Icon
2/14/2025Adage Capital Partners GP L.L.C.132,500$4.77M0.0%N/A2.991%Search for SEC Filing on Google Icon
2/14/2025Vivo Capital LLC251,572$9.06M1.0%N/A5.679%Search for SEC Filing on Google Icon
2/13/2025Walleye Capital LLC103,192$3.72M0.0%N/A2.327%Search for SEC Filing on Google Icon
2/13/2025Springhill Fund Asset Management HK Co Ltd60,648$2.19M3.5%N/A1.369%Search for SEC Filing on Google Icon
2/13/2025Atika Capital Management LLC15,000$0.54M0.1%N/A0.339%Search for SEC Filing on Google Icon
2/14/2024AdvisorShares Investments LLC188,119$0.27M0.1%+12.0%4.246%Search for SEC Filing on Google Icon
11/6/2023AdvisorShares Investments LLC167,930$0.27M0.1%-67.4%4.452%Search for SEC Filing on Google Icon
8/9/2023AdvisorShares Investments LLC515,315$0.29M0.1%+14.7%14.640%Search for SEC Filing on Google Icon
5/9/2023AdvisorShares Investments LLC449,155$0.20M0.1%+42.7%2.553%Search for SEC Filing on Google Icon
8/8/2022AdvisorShares Investments LLC289,576$0.24M0.1%+40.1%2.439%Search for SEC Filing on Google Icon
5/9/2022AdvisorShares Investments LLC206,716$0.31M0.1%+115.5%1.745%Search for SEC Filing on Google Icon
2/9/2022Checchi Capital Advisers LLC14,138$45K0.0%N/A0.119%Search for SEC Filing on Google Icon
1/31/2022AdvisorShares Investments LLC95,942$0.30M0.0%N/A0.810%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Bright Minds Biosciences logo
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio of selective 5-HT receptor agonists includes 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry; and BMB-101 which completes phase 1 trial for undisclosed seizure disorder. The company also developing BMB-202 for the treatment of depression, anxiety, and PTSD; and BMB-201 for the treatment of anxiety. It has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. Bright Minds Biosciences Inc. was founded in 2017 and is headquartered in New York, New York.
Read More on Bright Minds Biosciences

Today's Range

Now: $35.78
Low: $35.62
High: $36.78

50 Day Range

MA: $36.94
Low: $29.86
High: $46.29

52 Week Range

Now: $35.78
Low: $0.93
High: $79.02

Volume

30,403 shs

Average Volume

822,578 shs

Market Capitalization

$252.03 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Bright Minds Biosciences?

Bright Minds Biosciences' top insider investors include:
  1. Cormorant Asset Management, Lp (Major Shareholder)
Learn More about top insider investors at Bright Minds Biosciences.

Who are the major institutional investors of Bright Minds Biosciences?

Bright Minds Biosciences' top institutional investors include:
  1. Janus Henderson Group PLC — 11.48%
  2. RA Capital Management L.P. — 10.40%
  3. Vivo Capital LLC — 5.68%
  4. Point72 Asset Management L.P. — 3.05%
  5. Adage Capital Partners GP L.L.C. — 2.99%
  6. Walleye Capital LLC — 2.33%
Learn More about top institutional investors of Bright Minds Biosciences stock.

Which institutional investors are selling Bright Minds Biosciences stock?

In the previous quarter, DRUG stock was sold by these institutional investors:
  1. AdvisorShares Investments LLC

Which institutional investors are buying Bright Minds Biosciences stock?

In the previous quarter, DRUG stock was acquired by institutional investors including:
  1. Janus Henderson Group PLC
  2. RA Capital Management L.P.
  3. Vivo Capital LLC
  4. Point72 Asset Management L.P.
  5. Adage Capital Partners GP L.L.C.
  6. Walleye Capital LLC
  7. Schonfeld Strategic Advisors LLC
  8. Acuta Capital Partners LLC